Related Experiment Video

Updated: Aug 16, 2026

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
12:24

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse

Published on: June 20, 2014

Myocarditis and dilated cardiomyopathy: an inflammatory link

Jay W Mason1

  • 1Department of Internal Medicine, J527 Kentucky Clinic 0284, University of Kentucky, Lexington, KY 40506, USA. jmason12@charter.net

Cardiovascular Research
|October 3, 2003
PubMed

Insights

Myocarditis, an inflammation of the heart muscle, can lead to dilated cardiomyopathy (DCM). Viral myocarditis is strongly suspected in DCM development, prompting research into antiviral therapies.

Area of Science:

  • Cardiology
  • Virology
  • Immunology

Background:

  • Myocarditis presents complex pathogenetic mechanisms, often overlapping, complicating diagnosis and treatment.
  • Dilated cardiomyopathy (DCM) can be a sequela of myocarditis.
  • Increasing heart failure prevalence highlights the need for novel therapeutic strategies.

Purpose of the Study:

  • To explore the role of viral myocarditis in the etiology of dilated cardiomyopathy.
  • To review the evidence linking viral presence in the myocardium to DCM.
  • To advocate for the development of anti-viral and anti-inflammatory therapies for DCM prevention and amelioration.

Main Methods:

  • Review of existing evidence on myocarditis and DCM pathogenesis.
  • Analysis of studies detecting viral genetic material and proteins in DCM patient myocardium.
  • Synthesis of findings to support or refute the causal link between viral infections and DCM.

Main Results:

  • Circumstantial evidence suggests a significant role for viral myocarditis in DCM etiology.
  • Viral genetic material and proteins are frequently found in the myocardium of DCM patients.
  • Definitive proof of causality for viral infections in DCM remains elusive.

Conclusions:

  • Viral myocarditis is a likely contributor to the development of dilated cardiomyopathy.
  • Targeting viral and inflammatory pathways may offer a promising therapeutic approach to prevent or treat DCM.
  • Further research is needed to establish causality and refine treatment strategies.

More Related Videos

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells12:46

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...